Amgen Switzerland AG - Wezenla 45 mg/0.5 ml, Injektionslösung in einer Fertigspritze |
| 70188 | | 01 | | Wezenla 45 mg/0.5 ml | | Injektionslösung in einer Fertigspritze | | L04AC05 | | Ustekinumab | | 23.07.2025 | | |
|
Composition |
ustekinumabum 45 mg, saccharum, histidinum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. |
Packungsbestandteile |
| Injection solution in prefilled syringe | | | | Active Agent | Dose |
---|
| 45mg / 0.5ml |
| | Inactive agents |
---|
Histidine | Polysorbatum 80 | Saccharum |
|
|
Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
001 | | PR | PR | B | | Yes |
|